Mark K. Edwin, M.D.

The purpose of this study is an investigator-initiated, multi-site Mayo Clinic prospective minimal risk pilot study to determine feasibility and assess efficacy of an AI Assisted Personalized Legacy Program on the stress, dignity, spiritual wellbeing, and quality of life (QOL) of patients with serious illness. The AI Assisted Personalized Legacy Program intervention is a brief, individualized psychotherapy that aims to relieve psycho-emotional and existential distress and improve the experiences of patients whose lives are impacted by serious illness.  This therapy offers patients an opportunity to reflect on their life with a trained facilitator and share their thoughts and memories with family and other people in their life.

The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in order to improve patient clinical care at Mayo Clinic with more effective and efficient prescribing of medications

The purpose of  this study is to determine the usefulness of palliative care consultations by a specialty physician and a pulmonologist for patients who have advanced lung disease.

The purpose of this study is to measure the symptom response in patients with malignant bowel obstruction who have placement of a percutaneous transesophageal gastrostomy tube.

The purposes of this study are to evaluate: 

• The impact that a clinical pharmacist and pharmacogenomic testing has on symptom management;
• Patient perceptions, satisfaction and behaviors related to their medications and their view of the helpfulness of the pharmacist,
• The impact that a clinical pharmacist and pharmacogenomic testing has on overall cost of care; and
• The impact that a clinical pharmacist and pharmacogenomic testing has on average cost of medications.